blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0876146

EP0876146 - NUCLEOSIDE ANALOGS IN COMBINATION THERAPY OF HERPES SIMPLEX INFECTIONS [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  12.10.2012
Database last updated on 03.09.2024
Most recent event   Tooltip30.05.2014Lapse of the patent in a contracting state
New state(s): LU		published on 02.07.2014  [2014/27]
Applicant(s)For all designated states
Novartis International Pharmaceutical Ltd.
Sofia House, 48 Church Street
Hamilton HM 12 / BM
[2001/20]
Former [1998/46]For all designated states
SMITHKLINE BEECHAM PLC
New Horizons Court
Brentford, Middlesex TW8 9EP / GB
Inventor(s)01 / BOYD, Malcolm Richard, SmithKline Beecham Pharm.
Great Burgh, Yew Tree Bottom Road
Epsom, Surrey KT18 5XQ / GB
[1998/46]
Representative(s)Henkel & Partner mbB
Patentanwaltskanzlei, Rechtsanwaltskanzlei
Erika-Mann Strasse 23
80636 München / DE
[N/P]
Former [2011/44]Henkel, Breuer & Partner
Patentanwälte
Erika-Mann Strasse 23
80636 München / DE
Former [2008/49]Breuer, Markus, et al
Breuer & Müller Partnerschaft Patentanwälte Heimeranstrasse 35
80339 München / DE
Former [2002/36]Markus, Marc Andreas, et al
Novartis AG Patent & Trademark Department
CH-4002 Basel / CH
Former [2001/19]Vallet, Lucien, Dr., et al
Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach
4002 Basle / CH
Former [1998/46]Blakey, Alison Jane, et al
Smithkline Beecham, Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex, TW8 9EP / GB
Application number, filing date97901694.624.01.1997
[1998/46]
WO1997GB00226
Priority number, dateGB1996000154426.01.1996         Original published format: GB 9601544
[1998/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9726882
Date:31.07.1997
Language:EN
[1997/33]
Type: A1 Application with search report 
No.:EP0876146
Date:11.11.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 31.07.1997 takes the place of the publication of the European patent application.
[1998/46]
Type: B1 Patent specification 
No.:EP0876146
Date:02.05.2003
Language:EN
[2003/18]
Search report(s)International search report - published on:EP31.07.1997
ClassificationIPC:A61K31/52, A61K31/675, A61K38/13, A61P31/22, // (A61K31/675, 31:52),(A61K38/13, 31:52)
[2002/45]
CPC data not yet available
Former IPC [1998/46]A61K31/52
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/46]
Extension statesSI03.07.1998
TitleGerman:NUKLEOSIDDERIVATIVE IN KOMBINATIONSPRÄPARATEN ZUR BEHANDLUNG VON HSV KRANKHEITEN[1998/46]
English:NUCLEOSIDE ANALOGS IN COMBINATION THERAPY OF HERPES SIMPLEX INFECTIONS[1998/46]
French:ANALOGUES DE NUCLEOSIDES UTILISES DANS UNE THERAPIE COMBINEE CONTRE DES INFECTIONS DUES A L'HERPES SIMPLEX[1998/46]
Entry into regional phase13.07.1998National basic fee paid 
13.07.1998Designation fee(s) paid 
13.07.1998Examination fee paid 
Examination procedure21.08.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.07.1998Examination requested  [1998/46]
28.05.2001Despatch of a communication from the examining division (Time limit: M04)
02.10.2001Reply to a communication from the examining division
03.01.2002Despatch of a communication from the examining division (Time limit: M06)
11.07.2002Reply to a communication from the examining division
08.10.2002Communication of intention to grant the patent
18.02.2003Fee for grant paid
18.02.2003Fee for publishing/printing paid
Opposition(s)Opponent(s)01  02.02.2004    ADMISSIBLE
GLAXO GROUP LIMITED
Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
Opponent's representative
Breen, Anthony Paul, et al, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
 [N/P]
Former [2004/13]
Opponent(s)01  02.02.2004    ADMISSIBLE
GLAXO GROUP LIMITED
Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
Opponent's representative
Breen, Anthony Paul, et al, et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
12.03.2004Invitation to proprietor to file observations on the notice of opposition
15.09.2004Reply of patent proprietor to notice(s) of opposition
28.09.2004Communication of observations of patent proprietor (Time limit: M06)
08.04.2005Reply of parties involved to observations of patent proprietor
16.11.2006Despatch of a communication from the opposition division (Time limit: M06)
14.05.2007Reply to a communication from the opposition division
29.01.2008Date of oral proceedings
06.05.2008Despatch of interlocutory decision in opposition
06.05.2008Despatch of minutes of oral proceedings
26.06.2012Despatch of communication that the patent will be revoked
06.07.2012Legal effect of revocation of patent [ N /P ]
06.07.2012Legal effect of revocation of patent [2012/46]
Appeal following opposition15.07.2008Appeal received No.  T1358/08
16.09.2008Statement of grounds filed
12.06.2012Result of appeal procedure: revocation of the patent
Fees paidRenewal fee
25.01.1999Renewal fee patent year 03
27.12.1999Renewal fee patent year 04
05.01.2001Renewal fee patent year 05
11.12.2001Renewal fee patent year 06
31.01.2003Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMC31.01.2004
FI24.01.2011
GB24.01.2011
IE24.01.2011
IT24.01.2011
LU24.01.2011
ES25.01.2011
SE25.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
FR31.01.2011
LI31.01.2011
NL01.08.2011
DE02.08.2011
AT24.01.2012
[2014/27]
Former [2013/31]MC31.01.2004
FI24.01.2011
GB24.01.2011
IE24.01.2011
IT24.01.2011
ES25.01.2011
SE25.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
FR31.01.2011
LI31.01.2011
NL01.08.2011
DE02.08.2011
AT24.01.2012
Former [2013/21]MC31.01.2004
FI24.01.2011
GB24.01.2011
IE24.01.2011
IT24.01.2011
ES25.01.2011
SE25.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
FR31.01.2011
LI31.01.2011
NL01.08.2011
AT24.01.2012
Former [2013/07]MC31.01.2004
FI24.01.2011
GB24.01.2011
IE24.01.2011
IT24.01.2011
ES25.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
FR31.01.2011
LI31.01.2011
NL01.08.2011
AT24.01.2012
Former [2010/20]MC31.01.2004
Former [2007/34]MC31.01.2004
IT24.01.2005
Former [2005/02]MC31.01.2004
Cited inInternational search[X]US3317384  (UNDERWOOD GERALD E) [X] 1-6 * column W *;
 [X]GB1099385  (MERCK & CO INC) [X] 1-6 * examples 4,5 * * claims 1-20 *;
 [AD]WO9111187  (BEECHAM GROUP PLC [GB]) [AD] 1-6 * claims 1-11 *;
 [A]WO9200742  (BEECHAM GROUP PLC [GB]) [A] 1-6* claims 1-12 *;
 [PX]WO9624355  (ASTRA AB [SE], et al) [PX] 1-6 * claims 1-5,8-17 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.